{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:33:19Z","timestamp":1788975199229,"version":"build-2803163510"},"reference-count":155,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Osteosarcoma (OS) is a skeletal tumor affecting mainly children and adolescents. The presence of distance metastasis is frequent and it is localized preferentially to the lung, representing the main reason for death among patients. The therapeutic approaches are based on surgery and chemotherapeutics. However, the drug resistance and the side effects associated with the chemotherapy require the identification of new therapeutic approaches. The understanding of the complex biological scenario of the osteosarcoma will open the way for the identification of new targets for its treatment. Recently, a great interest of scientific community is for extracellular vesicles (EVs), that are released in the tumor microenvironment and are important regulators of tumor proliferation and the metastatic process. At the same time, circulating extracellular vesicles can be exploited as diagnostic and prognostic biomarkers, and they can be loaded with drugs as a new therapeutic approach for osteosarcoma patients. Thus, the characterization of OS-related EVs could represent a way to convert these vesicles from antagonists for human health into therapeutic and\/or diagnostic agents.<\/jats:p>","DOI":"10.3390\/ijms222212586","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T02:46:08Z","timestamp":1637721968000},"page":"12586","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Extracellular Vesicles in Osteosarcoma: Antagonists or Therapeutic Agents?"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7034-7718","authenticated-orcid":false,"given":"Viviana","family":"De Martino","sequence":"first","affiliation":[{"name":"Department of Clinical, Internal, Anaesthesiology and Cardiovascular Sciences, Sapienza University, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6844-6469","authenticated-orcid":false,"given":"Michela","family":"Rossi","sequence":"additional","affiliation":[{"name":"Bone Physiopathology Research Unit, Genetics and Rare Diseases Research Division, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9297-5184","authenticated-orcid":false,"given":"Giulia","family":"Battafarano","sequence":"additional","affiliation":[{"name":"Bone Physiopathology Research Unit, Genetics and Rare Diseases Research Division, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Pepe","sequence":"additional","affiliation":[{"name":"Department of Clinical, Internal, Anaesthesiology and Cardiovascular Sciences, Sapienza University, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6525-0439","authenticated-orcid":false,"given":"Salvatore","family":"Minisola","sequence":"additional","affiliation":[{"name":"Department of Clinical, Internal, Anaesthesiology and Cardiovascular Sciences, Sapienza University, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3848-412X","authenticated-orcid":false,"given":"Andrea","family":"Del Fattore","sequence":"additional","affiliation":[{"name":"Bone Physiopathology Research Unit, Genetics and Rare Diseases Research Division, Bambino Ges\u00f9 Children\u2019s Hospital, IRCCS, 00165 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ijc.24320","article-title":"International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons","volume":"125","author":"Mirabello","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Corre, I., Verrecchia, F., Crenn, V., Redini, F., and Trichet, V. (2020). The osteosarcoma microenvironment: A complex but targetable ecosystem. Cells, 9.","DOI":"10.3390\/cells9040976"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4419-0284-9_1","article-title":"The epidemiology of osteosarcoma","volume":"152","author":"Ottaviani","year":"2009","journal-title":"Cancer Treat Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nrc3838","article-title":"Translational biology of osteosarcoma","volume":"14","author":"Kansara","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bone.2016.10.017","article-title":"Molecular genetics of osteosarcoma","volume":"102","author":"Rickel","year":"2017","journal-title":"Bone"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/S0140-6736(07)60781-8","article-title":"Metastasis: Recent discoveries and novel treatment strategies","volume":"369","author":"Eccles","year":"2007","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10585-011-9384-x","article-title":"Molecular alterations as target for therapy in metastatic osteosarcoma: A review of literature","volume":"28","author":"PosthumaDeBoer","year":"2011","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/bjc.2014.585","article-title":"Recurrent osteosarcoma with a single pulmonary metastasis: A multi-institutional review","volume":"112","author":"Daw","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/gcc.10291","article-title":"Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma","volume":"39","author":"Lau","year":"2004","journal-title":"Genes Chromosom. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.celrep.2014.03.003","article-title":"Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma","volume":"7","author":"Chen","year":"2014","journal-title":"Cell Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nrendo.2017.16","article-title":"Germline and somatic genetics of osteosarcoma\u2014Connecting aetiology, biology and therapy","volume":"13","author":"Gianferante","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"8940","DOI":"10.1038\/ncomms9940","article-title":"Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency","volume":"6","author":"Kovac","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1002\/1097-0142(20011015)92:8<2181::AID-CNCR1561>3.0.CO;2-3","article-title":"Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma","volume":"92","author":"Gokgoz","year":"2001","journal-title":"Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/jnci\/95.9.669","article-title":"Association between osteosarcoma and deleterious mutations in the RECQL4 gene in Rothmund-Thomson syndrome","volume":"95","author":"Wang","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1073\/pnas.82.18.6216","article-title":"Osteosarcoma and retinoblastoma: A shared chromosomal mechanism revealing recessive predisposition","volume":"82","author":"Hansen","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1148\/radiology.152.3.6235535","article-title":"Bone sarcomas in Paget disease: A study of 85 patients","volume":"152","author":"Smith","year":"1984","journal-title":"Radiology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1051\/sicotj\/2017028","article-title":"Osteosarcoma: A comprehensive review","volume":"4","author":"Misaghi","year":"2018","journal-title":"SICOT J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1200\/JCO.1987.5.1.21","article-title":"Adjuvant chemotherapy for osteosarcoma: A randomized prospective trial","volume":"5","author":"Eilber","year":"1987","journal-title":"J. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1093\/annonc\/mdt252","article-title":"Limb preservation surgery with extracorporeal irradiation in the management of malignant bone tumor: The oncological outcomes of 101 patients","volume":"24","author":"Hong","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1200\/JCO.2014.59.4895","article-title":"Osteosarcoma: Current treatment and a collaborative pathway to success","volume":"33","author":"Isakoff","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jbo.2016.01.001","article-title":"A comparative study between limb-salvage and amputation for treating osteosarcoma","volume":"5","author":"Li","year":"2016","journal-title":"J. Bone Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3892\/etm.2012.685","article-title":"Meta-analysis of limb salvage versus amputation for treating high-grade and localized osteosarcoma in patients with pathological fracture","volume":"4","author":"Yin","year":"2012","journal-title":"Exp. Ther. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1470-2045(05)01734-1","article-title":"Surgical options for children with osteosarcoma","volume":"6","author":"Grimer","year":"2005","journal-title":"Lancet Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jcot.2012.04.004","article-title":"Current concepts in surgical treatment of osteosarcoma","volume":"3","author":"Tiwari","year":"2012","journal-title":"J. Clin. Orthop. Trauma"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00003086-199109000-00003","article-title":"Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study","volume":"270","author":"Link","year":"1991","journal-title":"Clin. Orthop. Relat. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/j.ejca.2011.05.030","article-title":"Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?","volume":"47","author":"Anninga","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"ref_27","first-page":"6228","article-title":"Progress in the chemotherapeutic treatment of osteosarcoma","volume":"16","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"38783","DOI":"10.1038\/srep38783","article-title":"Effect of unplanned therapy on the prognosis of patients with extremity osteosarcoma","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2125.2011.04054.x","article-title":"High dose methotrexate chemotherapy: Pharmacokinetics, folate and toxicity in osteosarcoma patients","volume":"73","author":"Holmboe","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jpeds.2008.11.030","article-title":"Methotrexate in pediatric osteosarcoma: Response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression","volume":"154","author":"Zalacain","year":"2009","journal-title":"J. Pediatr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1200\/JCO.2007.14.7793","article-title":"High-dose methotrexate in osteosarcoma: Let the questions surcease\u2014Time for final acceptance","volume":"26","author":"Jaffe","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1750-1172-2-6","article-title":"Osteosarcoma (osteogenic sarcoma)","volume":"2","author":"Picci","year":"2007","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.abb.2010.07.020","article-title":"Bone and bone marrow: The same organ","volume":"503","author":"Capannolo","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Yang, C., Tian, Y., Zhao, F., Chen, Z., Su, P., Li, Y., and Qian, A. (2020). Bone microenvironment and osteosarcoma metastasis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21196985"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1634\/stemcells.2005-0620","article-title":"Sarcoma derived from cultured mesenchymal stem cells","volume":"25","author":"Tolar","year":"2007","journal-title":"Stem Cells"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/stem.559","article-title":"Concise review: Dissecting a discrepancy in the literature: Do mesenchymal stem cells support or suppress tumor growth?","volume":"29","author":"Klopp","year":"2011","journal-title":"Stem Cells"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1517\/14712598.2015.997706","article-title":"Differential effects of extracellular vesicles secreted by mesenchymal stem cells from different sources on glioblastoma cells","volume":"15","author":"Luciano","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Cortini, M., Massa, A., Avnet, S., Bonuccelli, G., and Baldini, N. (2016). Tumor-activated mesenchymal stromal cells promote osteosarcoma stemness and migratory potential via IL-6 secretion. PLoS ONE, 11.","DOI":"10.1530\/boneabs.5.CABS.OP2.2"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/ijc.30540","article-title":"Cancer-associated mesenchymal stroma fosters the stemness of osteosarcoma cells in response to intratumoral acidosis via NF-kappaB activation","volume":"140","author":"Avnet","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/1878-0261.12189","article-title":"Bone marrow-derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition","volume":"12","author":"Pietrovito","year":"2018","journal-title":"Mol. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Le Nail, L.R., Brennan, M., Rosset, P., Deschaseaux, F., Piloquet, P., Pichon, O., Le Caignec, C., Crenn, V., Layrolle, P., and Herault, O. (2018). Comparison of tumor- and bone marrow-derived mesenchymal stromal\/stem cells from patients with high-grade osteosarcoma. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19030707"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Katayama, Y., Uchino, J., Chihara, Y., Tamiya, N., Kaneko, Y., Yamada, T., and Takayama, K. (2019). Tumor neovascularization and developments in therapeutics. Cancers, 11.","DOI":"10.3390\/cancers11030316"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature13145","article-title":"Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone","volume":"507","author":"Kusumbe","year":"2014","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature13146","article-title":"Endothelial Notch activity promotes angiogenesis and osteogenesis in bone","volume":"507","author":"Ramasamy","year":"2014","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"832649","DOI":"10.1155\/2015\/832649","article-title":"Endothelial progenitor cells in tumor angiogenesis: Another brick in the wall","volume":"2015","author":"Marcola","year":"2015","journal-title":"Stem Cells Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.yexcr.2018.05.008","article-title":"Migration-inducing gene-7 independently predicts poor prognosis of human osteosarcoma and is associated with vasculogenic mimicry","volume":"369","author":"Ren","year":"2018","journal-title":"Exp. Cell Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/09674845.2016.1220710","article-title":"miR-21 predicts poor prognosis in patients with osteosarcoma","volume":"73","author":"Ren","year":"2016","journal-title":"Br. J. Biomed. Sci."},{"key":"ref_48","first-page":"29","article-title":"VEGF-siRNA silencing induces apoptosis, inhibits proliferation and suppresses vasculogenic mimicry in osteosarcoma in vitro","volume":"30","author":"Mei","year":"2008","journal-title":"Exp. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e13102","DOI":"10.1111\/cpr.13102","article-title":"Current research progress in targeted anti-angiogenesis therapy for osteosarcoma","volume":"54","author":"Liu","year":"2021","journal-title":"Cell Prolif."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Lamora, A., Talbot, J., Mullard, M., Brounais-Le Royer, B., Redini, F., and Verrecchia, F. (2016). TGF-beta signaling in bone remodeling and osteosarcoma progression. J. Clin. Med., 5.","DOI":"10.3390\/jcm5110096"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1007\/s00018-015-1918-y","article-title":"Bone microenvironment signals in osteosarcoma development","volume":"72","author":"Alfranca","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Norregaard, K.S., Jurgensen, H.J., Gardsvoll, H., Engelholm, L.H., Behrendt, N., and Soe, K. (2021). Osteosarcoma and metastasis associated bone degradation\u2014A tale of osteoclast and malignant cell cooperativity. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22136865"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.1158\/0008-5472.CAN-09-4291","article-title":"Loss of osteoclasts contributes to development of osteosarcoma pulmonary metastases","volume":"70","author":"Cumming","year":"2010","journal-title":"Cancer Res."},{"key":"ref_54","first-page":"434","article-title":"The role of osteoclasts and tumour-associated macrophages in osteosarcoma metastasis","volume":"1826","author":"Evdokiou","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S1470-2045(16)30096-1","article-title":"Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): A randomised, multicentre, open-label, phase 3 trial","volume":"17","author":"Redini","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.fob.2015.08.002","article-title":"Pre-operative lymphocyte-to-monocyte ratio as a predictor of overall survival in patients suffering from osteosarcoma","volume":"5","author":"Liu","year":"2015","journal-title":"FEBS Open Bio"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1158\/1078-0432.CCR-10-2047","article-title":"Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: A rationale for treatment with macrophage activating agents","volume":"17","author":"Buddingh","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"78343","DOI":"10.18632\/oncotarget.13055","article-title":"Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma","volume":"7","author":"Dumars","year":"2016","journal-title":"Oncotarget"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1158\/2326-6066.CIR-19-0692","article-title":"Immunotherapy of pediatric solid tumors: Treatments at a crossroads, with an emphasis on antibodies","volume":"8","author":"Casey","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e990800","DOI":"10.4161\/2162402X.2014.990800","article-title":"CD8(+)\/FOXP3(+)-ratio in osteosarcoma microenvironment separates survivors from non-survivors: A multicenter validated retrospective study","volume":"4","author":"Fritzsching","year":"2015","journal-title":"Oncoimmunology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"30093","DOI":"10.1038\/srep30093","article-title":"Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma","volume":"6","author":"Koirala","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Mazumdar, A., Urdinez, J., Boro, A., Arlt, M.J.E., Egli, F.E., Niederost, B., Jaeger, P.K., Moschini, G., Muff, R., and Fuchs, B. (2020). Exploring the role of osteosarcoma-derived extracellular vesicles in pre-metastatic niche formation and metastasis in the 143-B xenograft mouse osteosarcoma model. Cancers, 12.","DOI":"10.3390\/cancers12113457"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/biosci\/biv084","article-title":"Extracellular vesicles: Composition, biological relevance, and methods of study","volume":"65","author":"Zaborowski","year":"2015","journal-title":"Bioscience"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"27066","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions","volume":"4","author":"Siljander","year":"2015","journal-title":"J. Extracell. Vesicles"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.1038\/ncomms9472","article-title":"Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs","volume":"6","author":"Phinney","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.nano.2011.04.003","article-title":"Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis","volume":"7","author":"Dragovic","year":"2011","journal-title":"Nanomedicine"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201211138","article-title":"Extracellular vesicles: Exosomes, microvesicles, and friends","volume":"200","author":"Raposo","year":"2013","journal-title":"J. Cell Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.02.013","article-title":"Biogenesis and function of extracellular vesicles in cancer","volume":"188","author":"Bebelman","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Doyle, L.M., and Wang, M.Z. (2019). Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells, 8.","DOI":"10.3390\/cells8070727"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.clinthera.2014.05.008","article-title":"Diagnostic and prognostic potential of extracellular vesicles in peripheral blood","volume":"36","author":"Revenfeld","year":"2014","journal-title":"Clin. Ther."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Ciferri, M.C., Quarto, R., and Tasso, R. (2021). Extracellular vesicles as biomarkers and therapeutic tools: From pre-clinical to clinical applications. Biology, 10.","DOI":"10.3390\/biology10050359"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41375-020-01104-1","article-title":"Clinical relevance of extracellular vesicles in hematological neoplasms: From liquid biopsy to cell biopsy","volume":"35","author":"Trino","year":"2021","journal-title":"Leukemia"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.2174\/0929867323666160627112827","article-title":"The immunoregulatory activity of mesenchymal stem cells: \u2018State of Art\u2019 and \u2018Future Avenues\u2019","volume":"23","author":"Fierabracci","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2174\/1568009616666160813190732","article-title":"New perspectives in glioblastoma: Nanoparticles-based approaches","volume":"17","author":"Luciano","year":"2017","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_75","first-page":"4331","article-title":"Expulsion of small molecules in vesicles shed by cancer cells: Association with gene expression and chemosensitivity profiles","volume":"63","author":"Shedden","year":"2003","journal-title":"Cancer Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12964-020-00643-5","article-title":"Role of extracellular vesicles in tumour microenvironment","volume":"18","author":"Tao","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jbo.2012.12.005","article-title":"Biological characterization of preclinical Bioluminescent Osteosarcoma Orthotopic Mouse (BOOM) model: A multi-modality approach","volume":"2","author":"Garimella","year":"2013","journal-title":"J. Bone Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"100280","DOI":"10.1016\/j.jbo.2020.100280","article-title":"Exosomes derived from bone marrow mesenchymal stem cells promote osteosarcoma development by activating oncogenic autophagy","volume":"21","author":"Huang","year":"2020","journal-title":"J. Bone Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2147\/OTT.S283459","article-title":"Bone marrow mesenchymal stem cells-derived extracellular vesicles promote proliferation, invasion and migration of osteosarcoma cells via the lncRNA MALAT1\/miR-143\/NRSN2\/Wnt\/beta-Catenin axis","volume":"14","author":"Li","year":"2021","journal-title":"OncoTargets Ther."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/15592294.2019.1585177","article-title":"Epigenetic alterations in mesenchymal stem cells by osteosarcoma-derived extracellular vesicles","volume":"14","author":"Mannerstrom","year":"2019","journal-title":"Epigenetics"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tranon.2014.04.011","article-title":"Extracellular membrane vesicles derived from 143B osteosarcoma cells contain pro-osteoclastogenic cargo: A novel communication mechanism in osteosarcoma bone microenvironment","volume":"7","author":"Garimella","year":"2014","journal-title":"Transl. Oncol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.matbio.2008.07.005","article-title":"MMP-1 (collagenase-1) and MMP-13 (collagenase-3) differentially regulate markers of osteoblastic differentiation in osteogenic cells","volume":"27","author":"Hayami","year":"2008","journal-title":"Matrix Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/mt.2011.53","article-title":"MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression","volume":"19","author":"Osaki","year":"2011","journal-title":"Mol. Ther."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.4049\/jimmunol.152.6.2768","article-title":"CD9-regulated adhesion. Anti-CD9 monoclonal antibody induce pre-B cell adhesion to bone marrow fibroblasts through de novo recognition of fibronectin","volume":"152","author":"Shaw","year":"1994","journal-title":"J. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1083\/jcb.129.6.1691","article-title":"Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)\/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites","volume":"129","author":"Nakamura","year":"1995","journal-title":"J. Cell Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1002\/eji.1830261117","article-title":"CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins","volume":"26","author":"Rubinstein","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0301-472X(99)00011-9","article-title":"CD9 molecule expressed on stromal cells is involved in osteoclastogenesis","volume":"27","author":"Tanio","year":"1999","journal-title":"Exp. Hematol."},{"key":"ref_88","first-page":"5211","article-title":"Overexpression of CD9 in human breast cancer cells promotes the development of bone metastases","volume":"32","author":"Kischel","year":"2012","journal-title":"Anticancer. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1743-6109.2006.00110.x","article-title":"Effect of platelet-rich plasma on migration and proliferation of SaOS-2 osteoblasts: Role of platelet-derived growth factor and transforming growth factor-beta","volume":"14","author":"Celotti","year":"2006","journal-title":"Wound Repair Regen."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/carcin\/bgz130","article-title":"Osteosarcoma cell-derived exosomes affect tumor microenvironment by specific packaging of microRNAs","volume":"41","author":"Raimondi","year":"2020","journal-title":"Carcinogenesis"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","article-title":"Tumor metastasis: Molecular insights and evolving paradigms","volume":"147","author":"Valastyan","year":"2011","journal-title":"Cell"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/(SICI)1097-0142(19970115)79:2<245::AID-CNCR7>3.0.CO;2-J","article-title":"Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions","volume":"79","author":"Bacci","year":"1997","journal-title":"Cancer"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1158\/1078-0432.CCR-04-1089","article-title":"Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma","volume":"11","author":"Laverdiere","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1002\/ijc.24665","article-title":"Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs","volume":"125","author":"Pradelli","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation\u2014A target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nm982","article-title":"The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis","volume":"10","author":"Khanna","year":"2004","journal-title":"Nat. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/onc.2008.437","article-title":"The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC","volume":"28","author":"Ren","year":"2009","journal-title":"Oncogene"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Kikuchi, S., Yoshioka, Y., Prieto-Vila, M., and Ochiya, T. (2019). Involvement of extracellular vesicles in vascular-related functions in cancer progression and metastasis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20102584"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Rossi, M., Battafarano, G., D\u2032Agostini, M., and Del Fattore, A. (2018). The role of extracellular vesicles in bone metastasis. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19041136"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Mazumdar, A., Urdinez, J., Boro, A., Migliavacca, J., Arlt, M.J.E., Muff, R., Fuchs, B., Snedeker, J.G., and Gvozdenovic, A. (2020). Osteosarcoma-derived extracellular vesicles induce lung fibroblast reprogramming. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155451"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3389\/fonc.2019.01342","article-title":"The emerging roles of extracellular vesicles in osteosarcoma","volume":"9","author":"Perut","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Perut, F., Roncuzzi, L., Zini, N., Massa, A., and Baldini, N. (2019). Extracellular nanovesicles secreted by human osteosarcoma cells promote angiogenesis. Cancers, 11.","DOI":"10.3390\/cancers11060779"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Endo-Munoz, L., Cai, N., Cumming, A., Macklin, R., Merida de Long, L., Topkas, E., Mukhopadhyay, P., Hill, M., and Saunders, N.A. (2015). Progression of osteosarcoma from a non-metastatic to a metastatic phenotype is causally associated with activation of an autocrine and paracrine uPA axis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0133592"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"43570","DOI":"10.18632\/oncotarget.9781","article-title":"Extracellular vesicles secreted by highly metastatic clonal variants of osteosarcoma preferentially localize to the lungs and induce metastatic behaviour in poorly metastatic clones","volume":"7","author":"Macklin","year":"2016","journal-title":"Oncotarget"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ccr.2014.03.007","article-title":"Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis","volume":"25","author":"Zhou","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.devcel.2019.04.011","article-title":"Exosome-mediated metastasis: Communication from a distance","volume":"49","author":"Wortzel","year":"2019","journal-title":"Dev. Cell"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.gene.2019.06.005","article-title":"Extracellular vesicles from osteosarcoma cell lines contain miRNAs associated with cell adhesion and apoptosis","volume":"710","author":"Jerez","year":"2019","journal-title":"Gene"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/jcb.27084","article-title":"MiR-143-3p suppresses cell proliferation, migration, and invasion by targeting Melanoma-Associated Antigen A9 in laryngeal squamous cell carcinoma","volume":"120","author":"Han","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.gene.2018.11.034","article-title":"Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients","volume":"687","author":"Ghaedi","year":"2019","journal-title":"Gene"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"87837","DOI":"10.18632\/oncotarget.21237","article-title":"Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer","volume":"8","author":"Jacob","year":"2017","journal-title":"Oncotarget"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"109627","DOI":"10.1016\/j.biopha.2019.109627","article-title":"Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcoma","volume":"121","author":"Wang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_113","first-page":"4211","article-title":"Highly enriched exosomal lncRNA OIP5-AS1 regulates osteosarcoma tumor angiogenesis and autophagy through miR-153 and ATG5","volume":"13","author":"Li","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Vervoort, S.J., Lourenco, A.R., van Boxtel, R., and Coffer, P.J. (2013). SOX4 mediates TGF-beta-induced expression of mesenchymal markers during mammary cell epithelial to mesenchymal transition. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0053238"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1091\/mbc.01-08-0398","article-title":"Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA","volume":"13","author":"Edlund","year":"2002","journal-title":"Mol. Biol. Cell"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/carcin\/bgw011","article-title":"The feedback loop between miR-124 and TGF-beta pathway plays a significant role in non-small cell lung cancer metastasis","volume":"37","author":"Zu","year":"2016","journal-title":"Carcinogenesis"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12<2230::AID-CNCR3>3.0.CO;2-Y","article-title":"Expression of transforming growth factor-beta (TGF-beta) isoforms in osteosarcomas: TGF-beta3 is related to disease progression","volume":"80","author":"Kloen","year":"1997","journal-title":"Cancer"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bone.2013.07.023","article-title":"Transforming growth factor beta 1 induces CXCL16 and leukemia inhibitory factor expression in osteoclasts to modulate migration of osteoblast progenitors","volume":"57","author":"Ota","year":"2013","journal-title":"Bone"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1158\/1078-0432.CCR-16-2726","article-title":"Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression","volume":"23","author":"Baglio","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.canlet.2012.06.006","article-title":"STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma","volume":"325","author":"Tu","year":"2012","journal-title":"Cancer Lett."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Corcoran, C., Rani, S., O\u2032Brien, K., O\u2032Neill, A., Prencipe, M., Sheikh, R., Webb, G., McDermott, R., Watson, W., and Crown, J. (2012). Docetaxel-resistance in prostate cancer: Evaluating associated phenotypic changes and potential for resistance transfer via exosomes. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0050999"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3892\/ijo.2016.3509","article-title":"Multimodal transfer of MDR by exosomes in human osteosarcoma","volume":"49","author":"Torreggiani","year":"2016","journal-title":"Int. J. Oncol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bbcan.2018.07.003","article-title":"Extracellular vesicles and anti-cancer drug resistance","volume":"1870","author":"Namee","year":"2018","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1615\/CritRevOncog.v20.i5-6.120","article-title":"Extracellular vesicle-mediated reversal of paclitaxel resistance in prostate cancer","volume":"20","author":"Wang","year":"2015","journal-title":"Crit. Rev. Oncog."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1038\/onc.2017.134","article-title":"Tumour exosomes from cells harbouring PTPRZ1-MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma","volume":"36","author":"Zeng","year":"2017","journal-title":"Oncogene"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/cbin.11532","article-title":"Cisplatin-resistant osteosarcoma cell-derived exosomes confer cisplatin resistance to recipient cells in an exosomal circ_103801-dependent manner","volume":"45","author":"Pan","year":"2021","journal-title":"Cell Biol. Int."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"75968","DOI":"10.18632\/oncotarget.18373","article-title":"Exosomes containing differential expression of microRNA and mRNA in osteosarcoma that can predict response to chemotherapy","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"719","DOI":"10.21873\/anticanres.14823","article-title":"Influence of canine macrophage-derived extracellular vesicles on apoptosis in canine melanoma and osteosarcoma cell lines","volume":"41","author":"Lee","year":"2021","journal-title":"Anticancer. Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.21037\/tcr-20-83","article-title":"Mesenchymal stem cell-derived exosomes carrying microRNA-150 suppresses the proliferation and migration of osteosarcoma cells via targeting IGF2BP1","volume":"9","author":"Xu","year":"2020","journal-title":"Transl. Cancer Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.2147\/IJN.S307843","article-title":"Drug delivery to the bone microenvironment mediated by exosomes: An axiom or enigma","volume":"16","author":"Samal","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"8603","DOI":"10.2147\/IJN.S218988","article-title":"A nanodrug consisting of doxorubicin and exosome derived from mesenchymal stem cells for osteosarcoma treatment in vitro","volume":"14","author":"Wei","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.2147\/OTT.S173110","article-title":"Targeted cancer therapy using engineered exosome as a natural drug delivery vehicle","volume":"11","author":"Gomari","year":"2018","journal-title":"Onco Targets Ther."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1021\/acs.molpharmaceut.9b00104","article-title":"Exosomes as drug carriers for cancer therapy","volume":"16","author":"Pullan","year":"2019","journal-title":"Mol. Pharm."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3389\/fphar.2018.01116","article-title":"A new approach for loading anticancer drugs into mesenchymal stem cell-derived exosome mimetics for cancer therapy","volume":"9","author":"Kalimuthu","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3389\/fbioe.2020.00748","article-title":"Recent advances on drug-loaded mesenchymal stem cells with anti-neoplastic agents for targeted treatment of cancer","volume":"8","author":"Babajani","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bbrc.2014.02.007","article-title":"Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration","volume":"445","author":"Shimbo","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"411","DOI":"10.7150\/thno.33482","article-title":"Extracellular vesicle-mediated delivery of miR-101 inhibits lung metastasis in osteosarcoma","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Huang, X., Yuan, T., Tschannen, M., Sun, Z., Jacob, H., Du, M., Liang, M., Dittmar, R.L., Liu, Y., and Liang, M. (2013). Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genom., 14.","DOI":"10.1186\/1471-2164-14-319"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/ki.2013.502","article-title":"Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine","volume":"86","author":"Cheng","year":"2014","journal-title":"Kidney Int."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1601-0825.2009.01604.x","article-title":"Exosomes from human saliva as a source of microRNA biomarkers","volume":"16","author":"Michael","year":"2010","journal-title":"Oral Dis."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12248-017-0160-y","article-title":"Preservation and storage stability of extracellular vesicles for therapeutic applications","volume":"20","author":"Jeyaram","year":"2017","journal-title":"AAPS J."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1172\/JCI81135","article-title":"The biology and function of exosomes in cancer","volume":"126","author":"Kalluri","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.3390\/ijms14035338","article-title":"Exosomes as intercellular signaling organelles involved in health and disease: Basic science and clinical applications","volume":"14","author":"Corrado","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/bs.acc.2015.12.005","article-title":"Tumor-derived exosomes and their role in cancer progression","volume":"74","author":"Whiteside","year":"2016","journal-title":"Adv. Clin. Chem."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41598-020-77398-z","article-title":"Extracellular vesicle-associated repetitive element DNAs as candidate osteosarcoma biomarkers","volume":"11","author":"Cambier","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"20360","DOI":"10.3402\/jev.v2i0.20360","article-title":"Standardization of sample collection, isolation and analysis methods in extracellular vesicle research","volume":"2","author":"Witwer","year":"2013","journal-title":"J. Extracell. Vesicles"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Thery","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/0471143030.cb0322s30","article-title":"Isolation and characterization of exosomes from cell culture supernatants and biological fluids","volume":"30","author":"Thery","year":"2006","journal-title":"Curr. Protoc. Cell Biol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymeth.2015.02.019","article-title":"Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes","volume":"87","author":"Taylor","year":"2015","journal-title":"Methods"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"8545347","DOI":"10.1155\/2018\/8545347","article-title":"Isolation of extracellular vesicles: General methodologies and latest trends","volume":"2018","author":"Konoshenko","year":"2018","journal-title":"Biomed Res. Int."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.tibtech.2020.05.012","article-title":"Technologies and standardization in research on extracellular vesicles","volume":"38","author":"Gandham","year":"2020","journal-title":"Trends Biotechnol."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Marchisio, M., Simeone, P., Bologna, G., Ercolino, E., Pierdomenico, L., Pieragostino, D., Ventrella, A., Antonini, F., Del Zotto, G., and Vergara, D. (2020). Flow cytometry analysis of circulating extracellular vesicle subtypes from fresh peripheral blood samples. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010048"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Szatanek, R., Baj-Krzyworzeka, M., Zimoch, J., Lekka, M., Siedlar, M., and Baran, J. (2017). The methods of choice for extracellular vesicles (EVs) characterization. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18061153"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nmeth.4185","article-title":"EV-TRACK: Transparent reporting and centralizing knowledge in extracellular vesicle research","volume":"14","author":"Consortium","year":"2017","journal-title":"Nat. Methods"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1535744","DOI":"10.1080\/20013078.2018.1535744","article-title":"Clinical research using extracellular vesicles: Insights from the international society for extracellular vesicles 2018 annual meeting","volume":"7","author":"Rayyan","year":"2018","journal-title":"J. Extracell. Vesicles"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/22\/12586\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:34:09Z","timestamp":1760168049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/22\/12586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":155,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["ijms222212586"],"URL":"https:\/\/doi.org\/10.3390\/ijms222212586","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,22]]}}}